LI-COR Adds Four New IRDye(R) Infrared Dye Antibodies to its Product Line

LINCOLN, Neb., Aug. 12 LI-COR Biosciences continues toexpand its offering of IRDye infrared dye-labeled antibodies for imagingapplications. The new IRDye(R) 680 Donkey Anti-Chicken IgG, IRDye 800CW DonkeyAnti-Chicken IgG, IRDye 680 Goat Anti-Rat IgG, and IRDye 800CW Goat Anti-RatIgG antibodies are highly cross-absorbed delivering high specificity formultiplex detection for multiple applications including quantitative Westerns,In-Cell Westerns, and in vivo small animal imaging.

IRDye(R) infrared dye antibodies are optimized for high sensitivity andexcellent signal-to-noise performance on LI-COR Odyssey(R) and Aerius(R)infrared imaging systems. Additional information on LI-COR IRDye Infrared Dyeantibodies is available at http://www.gotirdye.com.

About LI-COR Biosciences

LI-COR(R) Biosciences is a leading manufacturer of near-infrared imagingplatforms, analysis software, and LI-COR IRDye(R) infrared dye reagents forgenomic, proteomic, and molecular imaging applications. LI-COR pioneered thedevelopment of near-infrared fluorescence detection systems for DNA sequencingand today provides systems for drug discovery, protein research, small animalimaging, and undergraduate training.

LI-COR instruments for photosynthesis, carbon dioxide analysis and lightmeasurement are recognized worldwide for standard-setting innovation in plantscience research and environmental monitoring. Founded in 1971, the privatelyheld company is based in Lincoln, Nebraska, with subsidiaries in Germany andthe United Kingdom. LI-COR systems are used in over 100 countries and aresupported by a global network of distributors.

SOURCE LI-COR Biosciences

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...